|
Cours en clôture
01/09/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
4,350 CNY
|
-0,46%
|
 |
+1,16%
|
+41,69%
|
|
26/08 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2026
| | |
27/04 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2026
| | |
14/04 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2025
| | |
15/01 |
Harbin Gloria Pharmaceuticals Co., Ltd Approves Election of Xu Yuhong as Independent Director, Effective 14 January 2026
| | |
28/10/25 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2025
| | |
26/08/25 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2025
| | |
04/06/25 |
Harbin Gloria Pharmaceuticals Gets Right to Market Eisai's Mecobalamin Injection
| | |
27/05/25 |
Harbin Gloria Pharmaceuticals Signs Co-Promotion Deal for Lipid Drug
| | |
25/04/25 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2025
| | |
17/03/25 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Elects Liu Yueyin as A Non-Independent Director
| | |
14/03/25 |
Tranche Update on HARBIN GLORIA PHARMACEUTICALS Co., LTD's Equity Buyback Plan announced on October 22, 2024.
| | |
13/03/25 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD's Equity Buyback announced on October 22, 2024, has closed with 32,307,224 shares, representing 1.42% for CNY 79.99 million.
| | |
10/03/25 |
Tranche Update on HARBIN GLORIA PHARMACEUTICALS Co., LTD's Equity Buyback Plan announced on October 22, 2024.
| | |
07/02/25 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Announces Directorate Appointments
| | |
07/02/25 |
Declaration of Voting Results by Harbin Gloria Pharmaceuticals
| | |
26/01/25 |
Harbin Gloria Pharmaceuticals co Provides Information to the Shareholders
| | |
26/01/25 |
Shen Zhenyu Nominates Candidates to the Board of Harbin Gloria Pharmaceuticals
| | |
22/11/24 |
Harbin Gloria Pharmaceuticals Announces Results of the 2024 Third Extraordinary General Meeting
| | |
28/10/24 |
Shen Zhenyu Submits Proposal to Nominate Supervisors at Harbin Gloria Pharmaceuticals
| | |
28/10/24 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2024
| | |
22/10/24 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD announces an Equity Buyback for CNY 100 million worth of its shares.
| | |
21/10/24 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD authorizes a Buyback Plan.
| | |
23/08/24 |
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2024
| | |
19/08/24 |
Chinese Securities Watchdog Warns Harbin Gloria Pharma Over Information Inaccuracies
| | |
04/07/24 |
Harbin Gloria Pharmaceuticals' H1 Profit to Soar Up to 360%
| |
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
